TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CAI

Caris Life Sciences, Inc.

Healthcare · Biotechnology · —

32.00$ -0.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Caris Life Sciences, Inc. (CAI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 61 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CAI
Line item Q2 21 Q3 21 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
86 98 -74 -63 -69 -39 -31 7.3 62 45 33 61 201
29 33 18 12 12 11 7.0 6.4 4.9 4.3 5.1 12 26
0.6 0.6 4.5 4.5 4.7 5.0 15 28 14 13 16 38 81
28 22 -1.2 -4.1 -19 -1.7 13 -1.4 14 -59 8.3 -18 -55
105 545 1.7 2.6 1.8 2.3 2.7 1.4 7.1 5.1 10 32 55
-83 -515 60 -2.6 -1.8 -2.3 -2.7 -1.4 -7.1 -5.1 -10 -133 -155
7.4 7.4 – – – – – – – – – – –
– – 0.0 0.0 – – 0.0 0.0 -17 -0.1 0.0 -21 -38
– – 200 0.0 – – 0.0 24 0.0 4.0 0.0 -13 -9.0
-12 429 200 -0.1 0.1 0.2 1.3 681 -21 3.4 0.8 -36 -53
-9.4 11 186 -66 -71 -41 -33 687 34 43 23 -107 -6.6
-19 -448 -76 -66 -71 -41 -34 5.9 55 40 23 29 146

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?